Correction: Comprehensive genomic profiling of ESR1, PIK3CA, AKT1, and PTEN in HR(+)HER2(-) metastatic breast cancer: prevalence along treatment course and predictive value for endocrine therapy resistance in real-world practice
Breast Cancer Res Treat. 2024 Oct;207(3):611-614.
doi: 10.1007/s10549-024-07427-2.